Irit Sagi
23Patents
3h-index
24Co-inventors
63Inventor score
Filing activity: Jun 18, 2001 → Oct 9, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6744042B2 | Ion trapping | Electricity | 72 | Expired |
| US7524938B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Human Necessities | 9 | Expired |
| US9416195B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Chemistry; Metallurgy | 5 | Active |
| US10722560B2 | Compositions for remodeling extracellular matrix and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11382959B2 | Compositions for remodeling extracellular matrix and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US8697078B2 | Antibodies that inhibit metalloproteins | Chemistry; Metallurgy | 1 | Active |
| US10040868B2 | Antibodies targeted against LOXL-2 for the treatment of collagen-associated pathologies | Chemistry; Metallurgy | 1 | Active |
| US9764008B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 1 | Active |
| US10610588B2 | Methods of preventing secondary infections | Human Necessities | 1 | Active |
| US8486653B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Chemistry; Metallurgy | 1 | Active |
| US8324355B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Chemistry; Metallurgy | 1 | Active |
| US7558679B2 | System and method for irradiating a sample | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11779636B2 | Compositions for remodeling extracellular matrix and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9902783B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Chemistry; Metallurgy | 0 | Active |
| US12291578B2 | Anti-matrix metalloproteinase 7 (MMP-7) inhibitory antibody and uses thereof | Physics | 0 | Active |
| US10933122B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 0 | Active |
| US8999332B2 | Regulators of MMP-9 and uses thereof | Physics | 0 | Active |
| US9217041B2 | Antibodies that inhibit metalloproteins | Chemistry; Metallurgy | 0 | Active |
| US11400156B2 | Methods of preventing secondary infections | Human Necessities | 0 | Active |
| US8841108B2 | Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins | Human Necessities | 0 | Active |
| US10426821B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12343386B2 | Compositions for remodeling extracellular matrix and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10066024B2 | Methods of generating antibodies to metalloenzymes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.